Cell and gene therapies are currently at the forefront of scientific innovation. They hold great promise for patients suffering from a range of serious ailments.

The Canadian environment is a key opportunity for pharmaceutical manufacturers to launch therapies. This article considers the various stakeholders and elements that need to be considered when launching a specialty medication in Canada.